David Barton

Irishman, Interventional Cardiologist, #CTO #CHIP, gym rat, Leinster 🏉Opinions are my own.

[EHJ Editor-in-Chief @ehj_ed]

Lowering cumulative LDL-C exposure: the case for early treatment. Read more in EHJ.
https://t.co/otV2QJUfC7
#LDLC #CholesterolManagement #EarlyTreatment #LipidLowering #CardiovascularHealth #EHJ #Cardiology @escardio @ESC_Journals

[Gregg W. Stone MD @GreggWStone]

Complete revasc (CR) in pts with non-shock STEMI and multivessel ds. reduces MACE. But is the best timing for non-culprit lsn PCI immediate (during primary PCI) or staged? Our new meta-analysis publ in Circ CV Interv suggests immediate CR may increase mortality, same as in shock.

[Yiannis Chatzizisis @YChatzizisis]

Virtual head-to-head study of 7 postdilation techniques in provisional LM bifurcation PCI:
• POT-only or P-S-P: suboptimal
• Sequential + simultaneous KBI: best, especially in fibrotic/calcified plaques
• Final POT after KBI: no added benefit

[Umberto Barbero @BarberoUmberto]

Interesting paper about the value of #complexity in CTO PCI:

👉overall anatomical burden drives benefit;
👉higher SYNTAX score, greater prognostic gain;
👉CTO-PCI may protect donor vessels. ‼️Mortality reduced by 1.5% per +10 SYNTAX points‼️

https://t.co/SVRSXoxFXZ

[David Barton @drdaveybarton]

@Wisdom_HQ 2

[David Barton @drdaveybarton]

@lfc_lance Michael Owen

[David Barton @drdaveybarton]

@newstart_2024 He’s so ill informed - tragedy

[David Barton @drdaveybarton]

@bryan_johnson @RobertKennedyJr These are very poor quality studies you are citing! Not close to enough evidence to support your claims.

[David Barton @drdaveybarton]

@jl35wilsonMD @TheNarulaSeries @AntoniousAttall @Allison_Dupont @mmamas1973 @agtruesdell @_AdilShakil @adityadoc1 @nyalborgesmd @TWilsonMD @BaoGTran @Obisht Leave it! MSA >13.4 in NOBLE substudy predicted a TLR rate of 0 at 5 years 👍

[David Barton @drdaveybarton]

@OptimaCTO Less than I am able/want to!

[David Barton @drdaveybarton]

Fantastic review on estrogen and cardiovascular disease - a must read for #cardiotwitter https://t.co/MLglFbQy1S

[David Barton @drdaveybarton]

@mmamas1973 @drandrewsharp @nolanjimradial @djc795 @RodrigoBagur @SVRaoMD @MohanedEgred @AjayKirtane @cardioPCImom @jmahmed @ncurzen @Pooh_Velagapudi @mirvatalasnag @jedicath @Drroxmehran @GreggWStone @drrashid05 @mbmcentegart @rwyeh @perc_surgeon @omendiz @sbrugaletta @fischman_david @DocSavageTJU @Hragy @ShaziaTHussain1 Nice result! Crossover to the left main would be my approach to minimise likelihood of ISR given high plaque burden if nailing it. Invariably would upsize to 7.5 sheathless or switch to 8fr femoral and do a Triple kiss as risk of fenestration to large circ not insignificant

[David Barton @drdaveybarton]

@lamelaspablo @sbrugaletta @BifurcationClub @PCRonline @MilasinD18 @GoranEBC @EAPCIPresident Exactly!

[Dr. Bill Lombardi @DrBillLombardi]

https://t.co/rdWh1FD5ZF

[David Barton @drdaveybarton]

@HumansNoContext R

[Yiannis Chatzizisis @YChatzizisis]

Greater, faster, better!

Time to elevate CV interventions to the next level by integrating digital technologies!

Our review just came out in JACC Interventions: https://t.co/Bn2kprrIeP

And debriefing here:
https://t.co/nLiVihqFDR

@JACCJournals @umiamimedicine @unmc

[Regina Doherty MEP @ReginaDo]

Nail on head

[David Barton @drdaveybarton]

@PicturesFoIder 4

[JACC Journals @JACCJournals]

Given superior efficacy & similar overall safety, #P2Y12 inhibitor monotherapy might be preferred over #aspirin monotherapy for long-term secondary prevention in pts w/ established #cvCAD. https://t.co/EehIEuWqOt

#JACC #P2Y12i #CardioTwitter @FeliceGragnano @vlgmrc @Drroxmehran

[Tom O'Dowd @todowd]

Study of final medical students in @UCC on a career in GP.
“… students were discouraged from general practice by the denigration of general practice by hospital doctors …” IMJ May 23.
@MedCouncilIRL needs to take this in hand.